Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulmonary Function and Sleep-Related Disorders During Cervical Intrathecal Baclofen in Spinal Cord Injury
2023-508143-51-01Phase 4Authorised
- Sponsor
- Roessingh
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of baclofen in spinal cord injury (SCI) and Muscle spasm, sponsored by Roessingh. Planned start May 2024; status: authorised.
02
Drugs
baclofen
03
Conditions
spinal cord injury (SCI)Muscle spasm
Beyond the preview
Go deeper on 2023-508143-51-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-508143-51-01.